Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.

Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.

Item
http://www.wikidata.org/entity/Q42795664
JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strainsPyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial AgentsCoagulase-negative staphylococci.Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitalsIntrinsic and acquired resistance mechanisms in enterococcus.Linezolid dependence in Staphylococcus epidermidis bloodstream isolatesNationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.Eight-year (2002-2009) summary of the linezolid (Zyvox® Annual Appraisal of Potency and Spectrum; ZAAPS) program in European countries.Emergence and spread of cfr-mediated multiresistance in staphylococci: an interdisciplinary challenge.The oxazolidinones: past, present, and future.Antimicrobial resistance in internal medicine wards.Linezolid: a promising option in the treatment of Gram-positives.Mutations within the rplD Gene of Linezolid-Nonsusceptible Streptococcus pneumoniae Strains Isolated in the United StatesZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countries.Determination of disk diffusion and MIC quality control guidelines for JNJ-Q2, a novel quinolone.Effect of linezolid on serum PCT, ESR, and CRP in patients with pulmonary tuberculosis and pneumonia
P2860

Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.

Item
http://www.wikidata.org/entity/Q42795664
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Stability of linezolid activit ...... Potency and Spectrum program.
@en
Stability of linezolid activit ...... Potency and Spectrum program.
@nl
type
label
Stability of linezolid activit ...... Potency and Spectrum program.
@en
Stability of linezolid activit ...... Potency and Spectrum program.
@nl
prefLabel
Stability of linezolid activit ...... Potency and Spectrum program.
@en
Stability of linezolid activit ...... Potency and Spectrum program.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Stability of linezolid activit ...... Potency and Spectrum program.
@en
P2093
P304
P31
P356
10.1016/J.DIAGMICROBIO.2010.09.018
P433
P478
P577
P698